The efficacy and safety of liraglutide adjunct to insulin treatment in type 1 diabetes

Mise à jour : Il y a 4 ans
Référence : U1111-1138-0619

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To confirm superiority of liraglutide compared to placebo, both adjunct to insulin treatment, on glycaemic control, after 26 weeks of treatment in subjects with established type 1 diabetes in inadequate glycaemic control.


Critère d'inclusion

  • Diabetes Mellitus, Type 1